Ownership and insider activity for Aethlon Medical, Inc. (AEMD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses.
Price
| Price | $1.43 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.6M | $7.0M | $3.8M | $9.6M | $9.9M | $17.1M | $14.5M | $5.4M | $5.5M | $5.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | $74813 | 0 | $206729 | $149082 | $127965 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $1.6M | $7.2M | $4.0M | $10.0M | $10.4M | $18.2M | $15.1M | $6.2M | $5.9M | $5.6M |
| Property, Plant & Equipment | $29223 | $27552 | $6021 | $276910 | $201339 | $1.1M | $2.3M | $1.9M | $1.3M | $664642 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $84996 | $75832 | $66668 | $57504 | $56954 | $2200 | $1650 | $1100 | $550 | 0 |
| Total Assets | $1.7M | $7.4M | $4.1M | $10.4M | $10.7M | $19.4M | $17.5M | $8.2M | $7.4M | $6.3M |
| Accounts Payable | $484423 | $124450 | $131931 | $285036 | $337678 | $499962 | $432890 | $777862 | $534524 | $384550 |
| Short-term Debt | 0 | 0 | $962301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $611756 | $477957 | $1.8M | $1.1M | $1.4M | $1.8M | $1.5M | $1.8M | $1.9M | $1.4M |
| Long-term Debt | $519200 | $841153 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.1M | $1.3M | $1.8M | $1.1M | $1.4M | $2.4M | $2.4M | $2.5M | $2.2M | $1.4M |
| Retained Earnings | -$93.8M | -$99.5M | -$105.7M | -$112.0M | -$119.9M | -$130.3M | -$142.4M | -$154.6M | -$168.0M | -$175.1M |
| Total Equity | $676379 | $6.1M | $2.4M | $9.4M | $9.4M | $17.1M | $15.1M | $5.8M | $5.1M | $4.9M |
| Total Debt | $519200 | $841153 | $962301 | $141097 | $42543 | $729410 | $1.2M | $940316 | $649751 | $336718 |
| Net Debt | -$1.0M | -$6.1M | -$2.9M | -$9.5M | -$9.8M | -$16.3M | -$13.3M | -$4.5M | -$4.9M | -$4.7M |
| Working Capital | $985496 | $6.8M | $2.2M | $9.0M | $9.0M | $16.3M | $13.6M | $4.4M | $4.1M | $4.1M |
Financial Health
| Debt / Equity | 0.07 |
| Current Ratio | 5.42 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -34.28 |
Profitability
| Return on Equity | -123.09% |
| Return on Invested Capital | -127.19% |
| Return on Assets | -111.26% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ADAP · ALUR · CODX · ERNA · IINN · LNAI · NVNO
Explore sector: Healthcare · Medical - Devices
More sections of AEMD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks